BODI The Beachbody Company, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
BODI Stock | Fundamental Analysis & Investment Insights
NASDAQ
Communication Services
Internet Content & Information
Current Price
Live
$10.75
Analyst Target
$10.17
-5.4%
Downside
52W High
$12.33
52W Low
$3.38
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
65%
Analysis Accuracy
The Beachbody Company (BODI) exhibits severe financial distress as indicated by a critically low Piotroski F-Score of 2/9, signaling weak fundamental health. Despite a recent short-term price rally (+54.7% 1Y, +133.2% 6M), the company remains unprofitable with a -15.09% profit margin, deteriorating revenue (-41.40% YoY), and deeply negative ROE of -102.66%. Valuation metrics are distorted by negative earnings and missing enterprise data, while the lack of an Altman Z-Score prevents a full solvency assessment, though high debt/equity (1.03) and weak liquidity (current ratio 0.65) suggest elevated bankruptcy risk. Analysts recommend 'buy' with limited consensus (3 analysts), but this contradicts deteriorating fundamentals and extreme volatility in earnings.
Key Strengths
Recent quarterly earnings have consistently beaten expectations (3 of last 4 beats, avg +79.3% surprise)
High gross margin of 71.95% indicates strong pricing power or low cost of goods sold
Significant year-over-year EPS improvement (+149.0%) and Q/Q EPS growth (+160.0%) suggest potential earnings recovery
Trading above 52-week low ($3.38) with strong 6-month momentum (+133.2%)
Price/Sales ratio of 0.27 is low, potentially indicating undervaluation relative to sales
Key Risks
Piotroski F-Score of 2/9 indicates severe financial weakness and high risk of continued underperformance
Profitability remains negative with -15.09% net margin and no clear path to sustained profitability
Revenue declining sharply at -41.40% YoY, indicating fundamental business contraction
Extremely weak liquidity: current ratio of 0.65 and quick ratio of 0.38 suggest near-term solvency concerns
Negative ROE (-102.66%) and high debt/equity (1.03) signal aggressive leverage and poor capital efficiency
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare BODI against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning BODI from our newsroom.
Newest → oldest
No matching news yet.